Detalles de la búsqueda
1.
Sharing in care: engaging care partners in the care and communication of breast cancer patients.
Breast Cancer Res Treat
; 177(1): 127-136, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31165374
2.
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
Breast Cancer Res Treat
; 171(1): 121-129, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752687
3.
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
Cancer
; 119(6): 1140-8, 2013 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23065954
4.
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
Breast Cancer Res Treat
; 139(1): 135-43, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23588952
5.
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
Breast Cancer Res Treat
; 131(3): 915-24, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22076478
6.
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
Mod Pathol
; 25(3): 378-87, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22056952
7.
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer.
Breast Cancer Res Treat
; 127(1): 153-62, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21350820
8.
A randomized intervention involving family to improve communication in breast cancer care.
NPJ Breast Cancer
; 7(1): 14, 2021 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33579966
9.
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach.
JCO Oncol Pract
; 16(10): 665-674, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32603252
10.
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.
Clin Cancer Res
; 23(11): 2691-2701, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27979916
11.
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.
J Clin Oncol
; 34(36): 4390-4397, 2016 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27998227
12.
A Phase II study of the polyamine analog N1,N11-diethylnorspermine (DENSpm) daily for five days every 21 days in patients with previously treated metastatic breast cancer.
Clin Cancer Res
; 9(16 Pt 1): 5922-8, 2003 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14676116
13.
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.
J Nucl Med
; 56(1): 31-7, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25476537
14.
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.
J Clin Oncol
; 32(35): 3948-58, 2014 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25349302
15.
GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.
Hum Pathol
; 44(7): 1341-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23375642
16.
Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy.
Hum Pathol
; 43(7): 1003-11, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22154362
17.
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole.
Cancer Prev Res (Phila)
; 4(12): 1993-2001, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21885816
18.
Pulling the trigger.
J Clin Oncol
; 22(17): 3644-5, 2004 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15337815
19.
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer.
Clin Breast Cancer
; 10(1): 40-5, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20133257
20.
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.
J Clin Oncol
; 27(17): 2816-22, 2009 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19332718